Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
394 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Malaria - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Malaria - Pipeline Review, H2 2014', provides an overview of the Malaria's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malaria, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malaria and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Malaria - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Malaria and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Malaria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Malaria pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Malaria - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Malaria pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 6 Malaria Overview 7 Therapeutics Development 8 Malaria - Therapeutics under Development by Companies 10 Malaria - Therapeutics under Investigation by Universities/Institutes 16 Malaria - Pipeline Products Glance 20 Malaria - Products under Development by Companies 24 Malaria - Products under Investigation by Universities/Institutes 31 Malaria - Companies Involved in Therapeutics Development 36 Malaria - Therapeutics Assessment 100 Drug Profiles 112 Malaria - Recent Pipeline Updates 335 Malaria - Dormant Projects 359 Malaria - Discontinued Products 363 Malaria - Product Development Milestones 364 Appendix 373
List of Tables Number of Products under Development for Malaria, H2 2014 28 Number of Products under Development for Malaria - Comparative Analysis, H2 2014 29 Number of Products under Development by Companies, H2 2014 31 Number of Products under Development by Companies, H2 2014 (Contd..1) 32 Number of Products under Development by Companies, H2 2014 (Contd..2) 33 Number of Products under Development by Companies, H2 2014 (Contd..3) 34 Number of Products under Development by Companies, H2 2014 (Contd..4) 35 Number of Products under Investigation by Universities/Institutes, H2 2014 37 Number of Products under Investigation by Universities/Institutes, H2 2014 (Contd..1) 38 Number of Products under Investigation by Universities/Institutes, H2 2014 (Contd..2) 39 Comparative Analysis by Late Stage Development, H2 2014 40 Comparative Analysis by Clinical Stage Development, H2 2014 41 Comparative Analysis by Early Stage Development, H2 2014 42 Comparative Analysis by Unknown Stage Development, H2 2014 43 Products under Development by Companies, H2 2014 44 Products under Development by Companies, H2 2014 (Contd..1) 45 Products under Development by Companies, H2 2014 (Contd..2) 46 Products under Development by Companies, H2 2014 (Contd..3) 47 Products under Development by Companies, H2 2014 (Contd..4) 48 Products under Development by Companies, H2 2014 (Contd..5) 49 Products under Development by Companies, H2 2014 (Contd..6) 50 Products under Investigation by Universities/Institutes, H2 2014 51 Products under Investigation by Universities/Institutes, H2 2014 (Contd..1) 52 Products under Investigation by Universities/Institutes, H2 2014 (Contd..2) 53 Products under Investigation by Universities/Institutes, H2 2014 (Contd..3) 54 Products under Investigation by Universities/Institutes, H2 2014 (Contd..4) 55 Malaria - Pipeline by Genzyme Corporation, H2 2014 56 Malaria - Pipeline by Sanofi, H2 2014 57 Malaria - Pipeline by AstraZeneca PLC, H2 2014 58 Malaria - Pipeline by GlaxoSmithKline plc, H2 2014 59 Malaria - Pipeline by Inovio Pharmaceuticals, Inc., H2 2014 60 Malaria - Pipeline by GenVec, Inc., H2 2014 61 Malaria - Pipeline by Daiichi Sankyo Company, Limited, H2 2014 62 Malaria - Pipeline by Takeda Pharmaceutical Company Limited, H2 2014 63 Malaria - Pipeline by Imaxio SA, H2 2014 64 Malaria - Pipeline by FIT Biotech Oyj, H2 2014 65 Malaria - Pipeline by Novartis AG, H2 2014 66 Malaria - Pipeline by Actelion Ltd, H2 2014 67 Malaria - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2014 68 Malaria - Pipeline by Eisai Co., Ltd., H2 2014 69 Malaria - Pipeline by Pfizer Inc., H2 2014 70 Malaria - Pipeline by Sigma-Tau S.p.A., H2 2014 71 Malaria - Pipeline by CEL-SCI Corporation, H2 2014 72 Malaria - Pipeline by Crucell N.V., H2 2014 73 Malaria - Pipeline by Celgene Corporation, H2 2014 74 Malaria - Pipeline by 4SC AG, H2 2014 75 Malaria - Pipeline by Immtech Pharmaceuticals, Inc., H2 2014 76 Malaria - Pipeline by Mymetics Corporation, H2 2014 77 Malaria - Pipeline by IPCA Laboratories Limited, H2 2014 78 Malaria - Pipeline by Xenetic Biosciences plc, H2 2014 79 Malaria - Pipeline by Raptor Pharmaceuticals Corp., H2 2014 80 Malaria - Pipeline by D-Pharm Ltd., H2 2014 81 Malaria - Pipeline by Colby Pharmaceutical Company, H2 2014 82 Malaria - Pipeline by Bharat Biotech International Limited, H2 2014 83 Malaria - Pipeline by MerLion Pharmaceuticals Pte Ltd, H2 2014 84 Malaria - Pipeline by Mucosis B.V., H2 2014 85 Malaria - Pipeline by Protein Potential, LLC, H2 2014 86 Malaria - Pipeline by Amura Holdings Ltd., H2 2014 87 Malaria - Pipeline by Anacor Pharmaceuticals, Inc., H2 2014 88 Malaria - Pipeline by Telormedix SA, H2 2014 89 Malaria - Pipeline by Grupo Ferrer Internacional, S.A., H2 2014 90 Malaria - Pipeline by Chimerix, Inc., H2 2014 91 Malaria - Pipeline by Sanaria Inc., H2 2014 92 Malaria - Pipeline by NovaLead Pharma Pvt. Ltd., H2 2014 93 Malaria - Pipeline by Immunovaccine, Inc., H2 2014 94 Malaria - Pipeline by Acetylon Pharmaceuticals, Inc., H2 2014 95 Malaria - Pipeline by Etubics Corporation, H2 2014 96 Malaria - Pipeline by iBio, Inc., H2 2014 97 Malaria - Pipeline by Seek, H2 2014 98 Malaria - Pipeline by Cellceutix Corporation, H2 2014 99 Malaria - Pipeline by Genocea Biosciences, Inc., H2 2014 100 Malaria - Pipeline by Hawaii Biotech, Inc., H2 2014 101 Malaria - Pipeline by iQur Ltd., H2 2014 102 Malaria - Pipeline by Rodos BioTarget GmbH, H2 2014 103 Malaria - Pipeline by Sigma-Tau Pharmaceuticals, Inc, H2 2014 104 Malaria - Pipeline by Selecta Biosciences, Inc., H2 2014 105 Malaria - Pipeline by Cilian AG, H2 2014 106 Malaria - Pipeline by Artificial Cell Technologies, Inc., H2 2014 107 Malaria - Pipeline by KAEL-GemVax Co., Ltd., H2 2014 108 Malaria - Pipeline by Pfenex Inc., H2 2014 109 Malaria - Pipeline by Vaccibody AS, H2 2014 110 Malaria - Pipeline by VLP Biotech, Inc., H2 2014 111 Malaria - Pipeline by Lipotek Pty Ltd., H2 2014 112 Malaria - Pipeline by DesignMedix, Inc., H2 2014 113 Malaria - Pipeline by Conkwest, Inc., H2 2014 114 Malaria - Pipeline by Panacela Labs, Inc., H2 2014 115 Malaria - Pipeline by Akshaya Bio Inc., H2 2014 116 Malaria - Pipeline by Agilvax, Inc., H2 2014 117 Malaria - Pipeline by Fundacion Centro de Excelencia en Investigacion de Medicamentos Innovadores en Andalucia, MEDINA, H2 2014 118 Malaria - Pipeline by GlobalAcorn, H2 2014 119 Assessment by Monotherapy Products, H2 2014 120 Assessment by Combination Products, H2 2014 121 Number of Products by Stage and Target, H2 2014 124 Number of Products by Stage and Mechanism of Action, H2 2014 127 Number of Products by Stage and Route of Administration, H2 2014 129 Number of Products by Stage and Molecule Type, H2 2014 131 Malaria Therapeutics - Recent Pipeline Updates, H2 2014 355 Malaria - Dormant Projects, H2 2014 379 Malaria - Dormant Projects (Contd..1), H2 2014 380 Malaria - Dormant Projects (Contd..2), H2 2014 381 Malaria - Dormant Projects (Contd..3), H2 2014 382 Malaria - Discontinued Products, H2 2014 383
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
